FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eden Evins

Research Profile

Disorders

Procedures

Chemicals & Drugs

Activities & Behaviors

Concepts & Ideas

Physiology

Attention

Co-author Network

Publications

TOP 3
Janet Witte; Paola Pedrelli; Lee Baer; Kate Bentley; Alisabet J Clain; A Eden Evins; Maurizio Fava; David Mischoulon
A randomized, controlled, pilot study of acamprosate added to escitalopram in adults with major depressive disorder and alcohol use disorder.
A Eden Evins; Alan I Green; John M Kane; Robin M Murray
The effect of marijuana use on the risk for schizophrenia.
Sungwon Roh; A Eden Evins
Possible role of nicotine for the treatment of mild cognitive impairment.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eden Evins (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Janet Witte; Paola Pedrelli; Lee Baer; Kate Bentley; Alisabet J Clain; A Eden Evins; Maurizio Fava; David Mischoulon
A randomized, controlled, pilot study of acamprosate added to escitalopram in adults with major depressive disorder and alcohol use disorder.
Journal of clinical psychopharmacology 2012;32(6):787-96.
2012: A Eden Evins; Alan I Green; John M Kane; Robin M Murray
The effect of marijuana use on the risk for schizophrenia.
The Journal of clinical psychiatry 2012;73(11):1463-8.
2012: Sungwon Roh; A Eden Evins
Possible role of nicotine for the treatment of mild cognitive impairment.
Expert review of neurotherapeutics 2012;12(5):531-3.
2012: Elaine Weiner; M Patricia Ball; Alison S Buchholz; A Eden Evins; James M Gold; Robert P McMahon; Robert W Buchanan
Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
The Journal of clinical psychiatry 2012;73(1):95-102.
2011: A Eden Evins; Kate Bentley; Sara Carlini; Amy C Janes; Marc J Kaufman; Tsafrir Loebl; David Mischoulon; Johanna Nino-Gomez; Gladys Pachas; Nancy A Rigotti; Jessica Sousa; Karen Urbanoski; Maurizio Fava
A double-blind, placebo-controlled trial of the NMDA glycine site antagonist, GW468816, for prevention of relapse to smoking in females.
Journal of clinical psychopharmacology 2011;31(5):597-602.
2011: Yasmin Mashhoon; Gladys Pachas; Andrew P Prescot; Perry F Renshaw; A Eden Evins; Maurizio Fava; Amy C Janes; J Eric Jensen; Marc J Kaufman
Anterior cingulate proton spectroscopy glutamate levels differ as a function of smoking cessation outcome.
Progress in neuro-psychopharmacology & biological psychiatry 2011;35(7):1709-13.
2011: Nadia Iovieno; Kate H Bentley; A Eden Evins; Enrico Tedeschini; George I Papakostas
Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
The Journal of clinical psychiatry 2011;72(8):1144-51.
2010: A Eden Evins
Review: bupropion increases abstinence from smoking without affecting mental state in people with schizophrenia.
Evidence-based mental health 2010;13(4):120.
2010: Amy C Janes; Diego A Pizzagalli; Sarah Richardt; B de B Frederick; Avram J Holmes; Jessica Sousa; Maurizio Fava; A Eden Evins; Marc J Kaufman
Neural substrates of attentional bias for smoking-related cues: an FMRI study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(12):2339-45.
2010: Amy C Janes; Diego A Pizzagalli; Sarah Richardt; Blaise deB Frederick; Sarah Chuzi; Gladys Pachas; Melissa A Culhane; Avram J Holmes; Maurizio Fava; A Eden Evins; Marc J Kaufman
Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence.
Biological psychiatry 2010;67(8):722-9.
2010: David C Henderson; Bikash Sharma; Xiaoduo Fan; Paul M Copeland; Christina P Borba; Oliver Freudenreich; Corinne Cather; A Eden Evins; Donald C Goff
Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidone.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2010;22(1):33-42.
2009: Amy C Janes; Blaise deB Frederick; Sarah Richardt; Caitlin Burbridge; Emilio Merlo Pich; Perry F Renshaw; A Eden Evins; Maurizio Fava; Marc J Kaufman
Brain fMRI reactivity to smoking-related images before and during extended smoking abstinence.
Experimental and clinical psychopharmacology 2009;17(6):365-73.
2009: Oliver Freudenreich; David C Henderson; Eric A Macklin; A Eden Evins; Xiaoduo Fan; Corinne Cather; Jared P Walsh; Donald C Goff
Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial.
The Journal of clinical psychiatry 2009;70(12):1674-80.
2009: Marc J Kaufman; Andrew P Prescot; Dost Ongur; A Eden Evins; Tanya L Barros; Carissa L Medeiros; Julie Covell; Liqun Wang; Maurizio Fava; Perry F Renshaw
Oral glycine administration increases brain glycine/creatine ratios in men: a proton magnetic resonance spectroscopy study.
Psychiatry research 2009;173(2):143-9.
2009: David C Henderson; Xiaoduo Fan; Bikash Sharma; Paul M Copeland; Christina P Borba; Oliver Freudenreich; Corinne Cather; A Eden Evins; Donald C Goff
Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine.
Journal of psychiatric practice 2009;15(4):251-61.
2009: Diane L Santesso; A Eden Evins; Michael J Frank; Erika C Schetter; Ryan Bogdan; Diego A Pizzagalli
Single dose of a dopamine agonist impairs reinforcement learning in humans: evidence from event-related potentials and computational modeling of striatal-cortical function.
Human brain mapping 2009;30(7):1963-76.
2009: David C Henderson; Xiaoduo Fan; Paul M Copeland; Bikash Sharma; Christina P Borba; Ryan Boxill; Oliver Freudenreich; Corinne Cather; A Eden Evins; Donald C Goff
Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.
Journal of clinical psychopharmacology 2009;29(2):165-9.
2009: David C Henderson; Xiaoduo Fan; Paul M Copeland; Bikash Sharma; Christina P Borba; Sharon I Forstbauer; Kate Miley; Ryan Boxill; Oliver Freudenreich; Corinne Cather; A Eden Evins; Donald C Goff
Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia.
Human psychopharmacology 2009;24(3):225-32.
2009: Donald C Goff; Corinne Cather; Oliver Freudenreich; David C Henderson; A Eden Evins; Melissa A Culhane; Jared P Walsh
A placebo-controlled study of sildenafil effects on cognition in schizophrenia.
Psychopharmacology 2009;202(1-3):411-7.
2008: A Eden Evins; Melissa A Culhane; Jonathan E Alpert; Joel A Pava; Bruce S Liese; Amy Farabaugh; Maurizio Fava
A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
Journal of clinical psychopharmacology 2008;28(6):660-6.
2008: Donald C Goff; Corinne Cather; Jennifer D Gottlieb; A Eden Evins; Jared Walsh; Lisa Raeke; Michael W Otto; David Schoenfeld; Michael F Green
Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study.
Schizophrenia research 2008;106(2-3):320-7.
2008: Melissa A Culhane; David A Schoenfeld; Ruth S Barr; Corinne Cather; Thilo Deckersbach; Oliver Freudenreich; Donald C Goff; Nancy A Rigotti; A Eden Evins
Predictors of early abstinence in smokers with schizophrenia.
The Journal of clinical psychiatry 2008;69(11):1743-50.
2008: Nikos Makris; Gregory P Gasic; David Nelson Kennedy; Steven M Hodge; Jonathan R Kaiser; Myung Joo Lee; Byoung Woo Kim; Anne J Blood; A Eden Evins; Larry J Seidman; Dan V Iosifescu; Sang Lee; Claudia Baxter; Roy H Perlis; Jordan W Smoller; Maurizio Fava; Hans C Breiter
Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse?
Neuron 2008;60(1):174-88.
2008: Lindsay E Jubelt; Ruth S Barr; Donald C Goff; Tanya Logvinenko; Anthony P Weiss; A Eden Evins
Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia.
Psychopharmacology 2008;199(1):89-98.
2008: Michael A Dyer; Oliver Freudenreich; Melissa A Culhane; Gladys N Pachas; Thilo Deckersbach; Erin Murphy; Donald C Goff; A Eden Evins
High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia.
Schizophrenia research 2008;102(1-3):88-95.
2008: A Eden Evins; Donald C Goff
Varenicline treatment for smokers with schizophrenia: a case series.
The Journal of clinical psychiatry 2008;69(6):1016.
2008: Ruth S Barr; Diego A Pizzagalli; Melissa A Culhane; Donald C Goff; A Eden Evins
A single dose of nicotine enhances reward responsiveness in nonsmokers: implications for development of dependence.
Biological psychiatry 2008;63(11):1061-5.
2008: Xiaoduo Fan; David C Henderson; Dana D Nguyen; Corinne Cather; Oliver Freudenreich; A Eden Evins; Christina P Borba; Donald C Goff
Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia.
Psychiatry research 2008;159(1-2):140-6.
2008: Tsafrir Loebl; Gustavo A Angarita; Gladys N Pachas; Kai-Lin Huang; Sang H Lee; Johanna Nino; Tanya Logvinenko; Melissa A Culhane; A Eden Evins
A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent men.
The Journal of clinical psychiatry 2008;69(3):480-6.
2008: Diego A Pizzagalli; A Eden Evins; Erika Cowman Schetter; Michael J Frank; Petra E Pajtas; Diane L Santesso; Melissa Culhane
Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness.
Psychopharmacology 2008;196(2):221-32.
2008: Ruth S Barr; Melissa A Culhane; Lindsay E Jubelt; Rana S Mufti; Michael A Dyer; Anthony P Weiss; Thilo Deckersbach; John F Kelly; Oliver Freudenreich; Donald C Goff; A Eden Evins
The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(3):480-90.
2008: Alan J Gelenberg; Jose de Leon; A Eden Evins; Joseph J Parks; Nancy A Rigotti
Smoking cessation in patients with psychiatric disorders.
Primary care companion to the Journal of clinical psychiatry 2008;10(1):52-8.
2007: Alan J Gelenberg; Jose de Leon; A Eden Evins; Joseph J Parks; Nancy A Rigotti
Smoking cessation in patients with psychiatric disorders.
The Journal of clinical psychiatry 2007;68(9):1404-10.
2007: A Eden Evins; Corinne Cather; Melissa A Culhane; Alan Birnbaum; Jonathan Horowitz; Elaine Hsieh; Oliver Freudenreich; David C Henderson; David Schoenfeld; Nancy A Rigotti; Donald C Goff
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Journal of clinical psychopharmacology 2007;27(4):380-6.
2007: Xiaoduo Fan; David C Henderson; Elaine Chiang; Leah B Namey Briggs; Oliver Freudenreich; A Eden Evins; Corinne Cather; Donald C Goff
Sexual functioning, psychopathology and quality of life in patients with schizophrenia.
Schizophrenia research 2007;94(1-3):119-27.
2007: David C Henderson; X Fan; Paul M Copeland; Christina P Borba; Tara B Daley; Dana D Nguyen; H Zhang; Doug Hayden; Oliver Freudenreich; Corinne Cather; A Eden Evins; Donald C Goff
A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain.
Acta psychiatrica Scandinavica 2007;115(2):101-5.
2006: David C Henderson; Paul M Copeland; Christina P Borba; Tara B Daley; Dana D Nguyen; Enrico Cagliero; A Eden Evins; Hui Zhang; Doug Hayden; Oliver Freudenreich; Corinne Cather; David Schoenfeld; Donald C Goff
Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
The Journal of clinical psychiatry 2006;67(5):789-97.
2006: David C Henderson; Laura Kunkel; Dana D Nguyen; Christina P Borba; Tara B Daley; Pearl M Louie; Oliver Freudenreich; Corinne Cather; A Eden Evins; Donald C Goff
An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia.
Acta psychiatrica Scandinavica 2006;113(2):142-7.
2005: A Eden Evins; Thilo Deckersbach; Corinne Cather; Oliver Freudenreich; Melissa A Culhane; David C Henderson; Michael F Green; David Schoenfeld; Nancy A Rigotti; Donald C Goff
Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.
The Journal of clinical psychiatry 2005;66(9):1184-90.
2005: David C Henderson; Dana D Nguyen; Paul M Copeland; Doug Hayden; Christina P Borba; Pearl M Louie; Oliver Freudenreich; A Eden Evins; Corinne Cather; Donald C Goff
Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.
The Journal of clinical psychiatry 2005;66(9):1116-21.
2005: Oliver Freudenreich; Lawrence Herz; Thilo Deckersbach; A Eden Evins; David C Henderson; Corinne Cather; Donald C Goff
Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial.
Psychopharmacology 2005;181(2):358-63.
2005: A Eden Evins; Corinne Cather; Thilo Deckersbach; Oliver Freudenreich; Melissa A Culhane; Casey M Olm-Shipman; David C Henderson; David Schoenfeld; Donald C Goff; Nancy A Rigotti
A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia.
Journal of clinical psychopharmacology 2005;25(3):218-25.
2005: David C Henderson; Paul M Copeland; Tara B Daley; Christina P Borba; Corinne Cather; Dana D Nguyen; Pearl M Louie; A Eden Evins; Oliver Freudenreich; Doug Hayden; Donald C Goff
A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.
The American journal of psychiatry 2005;162(5):954-62.
2005: Donald C Goff; Lawrence Herz; Thomas A Posever; Vivian Shih; Guochuan Tsai; David C Henderson; Oliver Freudenreich; A Eden Evins; Iftah Yovel; Hui Zhang; David Schoenfeld
A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients.
Psychopharmacology 2005;179(1):144-50.
2005: Donald C Goff; Corinne Cather; A Eden Evins; David C Henderson; Oliver Freudenreich; Paul M Copeland; Michael Bierer; Kenneth Duckworth; Frank M Sacks
Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists.
The Journal of clinical psychiatry 2005;66(2):183-94; quiz 147, 273-4.
2004: Walter J O'Donnell; Richard L Kradin; A Eden Evins; Conrad Wittram
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-2004. A 52-year-old woman with recurrent episodes of atypical pneumonia.
The New England journal of medicine 2004;351(26):2741-9.
2004: Oliver Freudenreich; Corinne Cather; A Eden Evins; David C Henderson; Donald C Goff
Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.
The Journal of clinical psychiatry 2004;65(10):1372-6.
2004: Donald C Goff; Teodoro Bottiglieri; Erland Arning; Vivian Shih; Oliver Freudenreich; A Eden Evins; David C Henderson; Lee Baer; Joseph Coyle
Folate, homocysteine, and negative symptoms in schizophrenia.
The American journal of psychiatry 2004;161(9):1705-8.
2004: A Eden Evins; Corinne Cather; Nancy A Rigotti; Oliver Freudenreich; David C Henderson; Casey M Olm-Shipman; Donald C Goff
Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction.
The Journal of clinical psychiatry 2004;65(3):307-11; quiz 452-3.
2003: Maurizio Fava; A Eden Evins; David J Dorer; David Schoenfeld
The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach.
Psychotherapy and psychosomatics 2003;72(3):115-27.
2003: A Eden Evins
Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders.
The Journal of clinical psychiatry 2003;64 Suppl 8():9-14.
2002: A Eden Evins; Ed Amico; Thomas A Posever; Rob Toker; Donald C Goff
D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia.
Schizophrenia research 2002;56(1-2):19-23.
2002: Donald C Goff; John Hennen; In Kyoon Lyoo; Guochuan Tsai; Lawrence L Wald; A Eden Evins; Deborah A Yurgelun-Todd; Perry F Renshaw
Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine.
Biological psychiatry 2002;51(6):493-7.
2001: D C Goff; Oliver Freudenreich; A Eden Evins
Augmentation strategies in the treatment of schizophrenia.
CNS spectrums 2001;6(11):904, 907-11.
2001: A Eden Evins; V K Mays; Nancy A Rigotti; T Tisdale; Corinne Cather; Donald C Goff
A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2001;3(4):397-403.
1999: A Eden Evins; T Tisdale
Bupropion and smoking cessation.
The American journal of psychiatry 1999;156(5):798-9.
1999: Donald C Goff; David C Henderson; A Eden Evins; Ed Amico
A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia.
Biological psychiatry 1999;45(4):512-4.
1998: Donald C Goff; A Eden Evins
Negative symptoms in schizophrenia: neurobiological models and treatment response.
Harvard review of psychiatry 1998;6(2):59-77.
1997: A Eden Evins; Ed Amico; Vivian Shih; Donald C Goff
Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics.
Journal of neural transmission (Vienna, Austria : 1996) 1997;104(6-7):761-6.